SOURCE: StockCall


October 31, 2011 08:00 ET

Research on AmerisourceBergen Corporation and Omnicare Inc. - Generics Boost Wholesale Drugs Industry

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Oct 31, 2011) - offers investors comprehensive research on the Drugs Wholesale industry and has completed analytical research on AmerisourceBergen Corporation (NYSE: ABC) and Omnicare Inc. (NYSE: OCR). Register with us today at to have free access to these researches.

Overall drug prescriptions have decreased partly because of a weak flu season, a sluggish economy and high jobless rates that could be keeping uninsured and underinsured patients away from the doctor. Despite these negative trends, many companies in the Wholesale Drugs Industry continue to perform well for their investors on increased sales of generic drugs. Register now at to have free access to our reports on the Drugs Wholesale industry. is an online platform where investors doing their due-diligence on the Drugs Wholesale industry can have easy and free access to our analyst research and opinions on AmerisourceBergen Corporation and Omnicare Inc.; investors and shareholders of these companies can simply register for a complimentary membership at

Companies in the industry like AmerisourceBergen Corporation and Omnicare Inc. are providers of both brand name and generic prescription drugs. The popularity of generic drugs has helped companies such as these to weather the storm coming from government agencies such as the Centers for Medicare and Medicaid Services which is imposing new rules which may reduce the amount of medicine prescribed to seniors. Investors can register for free to access the research reports on AmerisourceBergen Corporation and Omnicare Inc. at or

Some analysts and investors alike are concerned over pending U.S. federal legislation coming down from the congressional super committee which will most likely bring significant cuts to the overall healthcare budget. Companies that are well positioned with lower cost generic versions of popular and much needed drugs could outperform their peers going forward. Visit to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information